STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7
Clinical trials for STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Punch attack on lung cancer: zap then cut
Disease control OngoingThis small, early-stage study is testing the safety of a two-step treatment for early-stage non-small cell lung cancer. First, patients receive a single, highly focused dose of radiation to their tumor. Then, about a month later, they have surgery to remove it. The goal is to see…
Matched conditions: STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Targeted drug trial aims to stop lung Cancer's comeback
Disease control OngoingThis study is testing if a drug called crizotinib can help prevent early-stage lung cancer from coming back after surgery. It is for patients whose cancer has a specific genetic change called ALK-positive. After surgery, participants are randomly assigned to either take the drug …
Matched conditions: STAGE IB NON-SMALL CELL LUNG CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC